Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2026-01-27 @ 3:56 AM
Study NCT ID:
NCT06429761
Status:
RECRUITING
Last Update Posted:
2025-11-24
First Post:
2024-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | BREAST CANCER | View |
Keywords: